Código QR

Clinical Assessment of Breast Cancer Resistance Protein (BCRP)-Mediated Drug–Drug Interactions of Sepiapterin with Curcumin and Rosuvastatin in Healthy Volunteers

Abstract Background and Objective Sepiapterin, also known as PTC923 and CNSA-001, is a synthetic form of endogenous sepiapterin being developed as a novel oral treatment for phenylketonuria. Sepiapterin is a natural precursor of tetrahydrobiopterin (BH4) and, when orally administered, is converted t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Lan Gao, Diksha Kaushik, Kimberly Ingalls, Sarah Milner, Neil Smith, Ronald Kong
Formato: Artigo
Idioma:Inglês
Publicado: Adis, Springer Healthcare 2024-09-01
Series:Drugs in R&D
Acceso en liña:https://doi.org/10.1007/s40268-024-00488-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!